Purchase Order 75N95024P00372
- Not listed
- This is a $3,849,800.00 firm fixed-price purchase order contract awarded to Psomagen Inc., a small business, by the National Institute on Aging (NIA), a component of the National Institutes of Health (NIH). The contract is for neurodegenerative disease research, including whole genome sequencing services, with a completion date of September 14, 2024. Psomagen Inc. is a subsidiary of Macrogen, Inc. and is a provider of genomic sequencing, bioinformatics, and related services to federal government...
- This federal contract award is for $313,500.00 in single cell multiome sequencing services, provided by Psomagen Inc., a subsidiary of Macrogen, Inc. The contract was awarded by the National Institute on Aging (NIA), a civilian agency within the National Institutes of Health (NIH). The contract is a firm fixed price purchase order with a period of performance through March 1, 2026. Psomagen Inc. is a prime contractor that specializes in delivering a wide range of genomic and molecular biology...
- This federal contract, awarded by the National Institute on Aging (a civilian agency of the U.S. government), is for the purchase of whole genome sequencing services from the prime contractor, Psomagen Inc. The contract has a total ceiling value of $7,499,725.00 and is set aside for small businesses. Psomagen Inc. is a subsidiary of Macrogen, Inc. that specializes in providing a range of genomic sequencing, bioinformatics, and related services to federal agencies. Through this contract, Psomagen...
- The National Institute on Aging (NIA), a civilian agency within the Department of Health and Human Services, awarded a $532,500 firm-fixed-price purchase order contract to Psomagen Inc., a small business contractor, for long read sequencing services. This contract supports the Global Parkinson's Genetics Program (GP2) research initiative and requires Psomagen to perform whole genome sequencing of 500 human DNA samples at 25X coverage. Psomagen is a multiomics contract laboratory that specializes...
- This is a $64,800 firm-fixed price purchase order awarded by the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), to Psomagen Inc. for RNA sequencing services to support neurodegenerative disease research. The contract has a period of performance from August 1, 2024 to December 31, 2024. Psomagen will provide total RNA sequencing, including library preparation, sequencing, and data delivery, for 324 human samples. This is a non-competitive award, as Psomagen...
- <p>The National Institutes of Health National Institute on Aging awarded a $288,900.00 purchase order to Psomagen Inc., a subsidiary of Macrogen, Inc., to provide single cell multiome sequencing services from July 3, 2023 through July 2, 2024. The firm fixed price contract will support Psomagen in conducting single cell multiome sequencing at its facility located in Potomac, Maryland to assist the National Institutes of Health National Institute on Aging in advancing biomedical research.</p>
- <p>The Department of Health and Human Services National Institutes of Health National Institute on Aging (HHS-NIH-NIA) awarded a $600,000 purchase order contract to Psomagen Inc., a subsidiary of Macrogen, Inc., to provide Epigenome Sequencing Services. The contract has a period of performance starting on June 1, 2023 through May 31, 2024 and utilizes a firm fixed price pricing structure. The place of performance will be Potomac, Maryland. No subcontractors were identified.</p>
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Psomagen Inc., a subsidiary of Macrogen, Inc. The $30,000 firm fixed-price purchase order was not set aside for any specific business type. Under this contract, Psomagen will provide a range of genomic and molecular biology services to support research across various NIH institutes, including the National Institute on Aging,...
- This federal contract award to Psomagen Inc., a subsidiary of Macrogen, Inc., is for epigenome sequencing services using the Illumina NovaSeq platform. The $83,750 firm fixed-price purchase order was awarded by the National Institute on Aging, a civilian agency within the National Institutes of Health. The award was not set aside for small businesses. Psomagen Inc. is an experienced provider of genomic services to federal agencies, having supported research initiatives at the NIH, USDA, and...
- This firm-fixed-price purchase order was awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency within the National Institutes of Health (NIH), to Psomagen Inc., a for-profit organization and manufacturer of goods. The $23,030 contract is for OLINK HT ANALYSIS services, which likely refers to genomic sequencing and analysis capabilities provided by Psomagen. The contract has an ultimate completion date of July 29, 2025 and was awarded on July 30, 2024...
The National Institute on Aging (NIA), a civilian agency within the U.S. government, has awarded a $237,440.00 firm fixed-price purchase order to Psomagen Inc., a for-profit organization and manufacturer of goods, to provide next-generation sequencing analysis services on post-mortem frontal cortex tissues. The contract has an ultimate completion date of July 31, 2025. This award is not associated with a set-aside program. Psomagen Inc. is a subsidiary of Macrogen, Inc. and is a multiomics contract laboratory service and data analysis provider that specializes in delivering a wide range of genomic and molecular biology services to federal government agencies, particularly within the health and agricultural sectors. The company has previously supported research on neurodegenerative diseases, cancer, infectious diseases, and agricultural genetics through various federal contract awards and sub-awards. This contract award represents Psomagen's continued role in providing advanced sequencing and omics services to the NIA to further its research efforts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $237.4k | 7/25/24 |